AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
ASPX was delisted on the 4th of May, 2015.
138 hedge funds and large institutions have $1.91B invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 21 closing their positions.
704% more call options, than puts
Call options by funds: $14.8M | Put options by funds: $1.85M
233% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 21
147% more capital invested
Capital invested by funds: $773M → $1.91B (+$1.14B)
105% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 20
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
55% more funds holding
Funds holding: 89 → 138 (+49)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$99.9M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$41.7M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$38.8M |
| 4 |
WIC
Water Island Capital
New York
|
+$33.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$152M |
| 2 |
Jennison Associates
New York
|
-$29.4M |
| 3 |
KCM
Kingdon Capital Management
New York
|
-$21.1M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$20M |
| 5 |
Bank of New York Mellon
New York
|
-$7.98M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCI
151
Columbus Circle Investors
| – | -$838K | -15,976 | Closed |
|
152
Public Employees Retirement Association of Colorado
Denver,
Colorado
| – | -$799K | -15,232 | Closed |
|
153
Renaissance Technologies
New York
| – | -$535K | -10,200 | Closed |
|
|
TI
154
Trexquant Investment
Stamford,
Connecticut
| – | -$498K | -9,495 | Closed |
|
155
Two Sigma Investments
New York
| – | -$409K | -7,800 | Closed |
|
156
Wellington Management Group
Boston,
Massachusetts
| – | -$359K | -6,840 | Closed |
|
|
EMG
157
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$226K | -4,300 | Closed |
|
158
Two Sigma Advisers
New York
| – | -$210K | -4,000 | Closed |
|
|
QT
159
Quantbot Technologies
New York
| – | -$45K | -871 | Closed |
|
ASPX Hedge Fund Activity: Q1 2015 in Review
138 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q1 2015, worth a combined $1.91B — up 147% from $773M a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new ASPX positions and 21 closed out — a net gain of 49 holders — while 41 added to existing stakes and 20 trimmed.
The largest buyer was Deerfield Management, adding an estimated $99.9M. The largest seller was Fidelity Investments, cutting an estimated $152M.
- 138 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q1 2015, up from 89 in Q4 2014.
- Funds reported $1.91B of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2015, up 147% quarter-over-quarter.
- 70 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2015 and 21 closed out, a net change of +49 holders.
- The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2015 was Deerfield Management, an estimated $99.9M added.
- The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q1 2015 was Fidelity Investments, an estimated $152M sold.
Based on aggregated 13F filings for Q1 2015.